{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:16:16Z","timestamp":1792012576064,"version":"4.4.0"},"reference-count":15,"publisher":"British Editorial Society of Bone & Joint Surgery","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/online.boneandjoint.org.uk\/TDM"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery. British volume"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p> We carried out a retrospective review over ten months of patients who had presented with a low-energy subtrochanteric fracture. We identified 13 women of whom nine were on long-term alendronate therapy and four were not. The patients treated with alendronate were younger, with a mean age of 66.9 years (55 to 82) vs 80.3 years (64 to 92) and were more socially active. The fractures sustained by the patients in the alendronate group were mainly at the femoral metaphyseal-diaphyseal junction and many had occurred after minimal trauma. Five of these patients had prodromal pain in the affected hip in the months preceding the fall, and three demonstrated a stress reaction in the cortex in the contralateral femur. <\/jats:p><jats:p> Our study suggests that prolonged suppression of bone remodelling with alendronate may be associated with a new form of insufficiency fracture of the femur. We believe that this finding is important and indicates the need for caution in the long-term use of alendronate in the treatment of osteoporosis. <\/jats:p>","DOI":"10.1302\/0301-620x.89b3.18146","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T19:09:59Z","timestamp":1173812999000},"page":"349-353","source":"Crossref","is-referenced-by-count":362,"title":["Subtrochanteric insufficiency fractures in patients on alendronate therapy"],"prefix":"10.1302","volume":"89-B","author":[{"given":"S.-K.","family":"Goh","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Y.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S. B.","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Y.","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Changi General Hospital, 2, Simei Street 3, Singapore, 529889, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T. C.","family":"Chua","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Changi General Hospital, 2, Simei Street 3, Singapore, 529889, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Howe","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Singapore General Hospital, Outram Road, Singapore, 169608, Republic of Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"42","reference":[{"key":"R1","unstructured":"No authors listed. USA Food and Drug Administration 1995 http:\/\/www.access-data.fda.gov\/scripts\/cder\/ob\/docs\/obdetail.cfm?Appl_No=020560&\nTABLE1=OB_Rx (date last accessed 1st February 2007)."},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.11.6953"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Schatzker J. Subtrochanteric fractures of the femur. In: Schatzker J, Tile M, eds. The rationale of operative fracture care. 2nd edition. Springer 1995.","DOI":"10.1007\/978-3-642-88443-6"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137\u201341.","DOI":"10.1002\/jbmr.5650090802"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Pauwels F. Die bedeutung der bauprinzipien des stutz- und bewegungsapparates fur die beanspruchung der r\u00f6hrenknochen. Anatomy and Embryology 1948;114:1\u20132.","DOI":"10.1007\/BF00523560"},{"key":"R7","unstructured":"LaVelle DG. Fractures of the hip. In: Canale ST, ed. Campbell\u2019soperative orthopaedics. Vol. 3. Tenth edition. St. Louis: Mosby 2002:2873\u2013938."},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Fleisch H, Reszka A, Rodan G, Rogers M. Bisphosphonates: mechanisms of action. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 2nd ed. Vol. 1. San Diego: Academic Press, 2002:1361\u201385.","DOI":"10.1016\/B978-012098652-1\/50180-3"},{"key":"R9","unstructured":"National Osteoporosis Foundation (NOF) Physician\u2019s Guide to Prevention and Treatment of Osteoprosis. Available online at http:\/\/www.nof.org\/\/phys-guide\/risk_assessment.htm (date last accessed 12 March 2006)."},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030897"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00376-8"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119668"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0952"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Mashiba T, Hirano T, Turner CH, et al. Suppressed bone turnover by bisphosphonates increases microdamage acculumation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000;15:613\u201320.","DOI":"10.1359\/jbmr.2000.15.4.613"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa023110"}],"container-title":["The Journal of Bone and Joint Surgery. British volume"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.89B3.18146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/full-xml\/10.1302\/0301-620X.89B3.18146","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/0301-620X.89B3.18146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T20:39:35Z","timestamp":1629146375000},"score":1,"resource":{"primary":{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/10.1302\/0301-620X.89B3.18146"}},"subtitle":["A CAUTION"],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1302\/0301-620X.89B3.18146"],"URL":"https:\/\/doi.org\/10.1302\/0301-620x.89b3.18146","relation":{},"ISSN":["0301-620X","2044-5377"],"issn-type":[{"value":"0301-620X","type":"print"},{"value":"2044-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}